The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Ballantyne Charles Evan since year 2005.
The trader's CIK number is 1371742.
At the time of this reporting, Ballantyne Charles Evan is the Chief Financial Officer of Antigenics Inc /de/ .
(stock ticker symbol AGEN).
See this page for all insider trading activities at Antigenics Inc /de/ .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2015-09-25||AGEN||Antigenics Inc /de/||Buy||10,000||5.05||50,500|
|2014-05-22||SYN||Sheffield Pharmaceuticals Inc||Buy||10,000||1.35||13,500|
|2007-12-14||CLDA||Clinical Data Inc||Buy||1,650||21.52||35,512|
|2007-12-14||CLDA||Clinical Data Inc||Buy||200||22.00||4,400|
|2007-09-06||CLDA||Clinical Data Inc||Buy||1,500||26.48||39,727|
|2006-12-11||CLDA||Clinical Data Inc||Buy||600||16.79||10,074|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ballantyne Charles Evan (Chief Financial Officer of Antigenics Inc /de/ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.